SpringerLink
Log in

Protective effect of cardamonin against acetic acid-induced ulcerative colitis in rats

  • Original Article
  • Published:
Pharmacological Reports Aims and scope Submit manuscript

Abstract

Background

Ulcerative colitis (UC) is an inflammatory bowel disease with significant morbidity. Cardamonin is a natural chalcone derivative with considerable anti-inflammatory activity. Herein, the potential protective effect of cardamonin against UC was tested in a rat model.

Methods

Rats were given 10 or 30 mg/kg/day of cardamonin orally for 14 days before induction of UC. On the 14th day of treatment, UC was induced by intrarectal instillation of 2 ml 3% acetic acid. Twenty four h after acetic acid instillation, rats were sacrificed and colons were analyzed by macroscopic and histopathological examination. Colon lipid peroxidation was examined by biochemical evaluation of malondialdehyde (MDA). Myeloperoxidase (MPO), iNOS, NF-κB, TNFα levels were measured by ELISA. Moreover, caspase-3 and COX-2 were assessed by immunohistochemical analysis.

Results

Cardamonin at 10 and 30 mg/kg decreased the disease activity index and macroscopic damage index scores, and significantly reduced histopathological deterioration. Additionally, cardamonin reduced levels of MPO, iNOS, NF-κB, TNFα and MDA (p < 0.05). Immunohistochemistry revealed down-regulation of COX-2 and caspase-3 in groups treated with cardamonin.

Conclusion

Cardamonin has a protective effect against acetic acid-induced colitis. This effect may be due to reducing inflammation, oxidative stress and apoptosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lau MS, Tsai HH. Review of vedolizumab for the treatment of ulcerative colitis. World J Gastrointest Pharmacol Ther 2016;7:107–11.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet (London, England) 2007;369:1627–40.

    Article  CAS  Google Scholar 

  3. de Dombal FT. Ulcerative colitis. Epidemiology and aetiology, course and prognosis. Br Med J 1971;1:649–50.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46–54.

    Article  PubMed  Google Scholar 

  5. Furfaro F, Bezzio C, Ardizzone S, Massari A, de Franchis R, Maconi G. Overview of biological therapy in ulcerative colitis: current and future directions. J Gastrointestin Liver Dis 2015;24:203–13.

    PubMed  Google Scholar 

  6. Clark M, Colombel J-F, Feagan BC, Fedorak RN, Hanauer SB, Kamm MA, et al. American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21–23, 2006. Gastroenterology 2007;133:312–39.

    Article  PubMed  Google Scholar 

  7. Seril DN, Liao J, Yang G-Y, Yang CS. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 2003;24:353–62.

    Article  CAS  PubMed  Google Scholar 

  8. Singer II, Kawka DW, Scott S, Weidner JR, Mumford RA, Riehl TE, et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996;111:871–85.

    Article  CAS  PubMed  Google Scholar 

  9. Sklyarov AY, Panasyuk NB, Fomenko IS. Role of nitric oxide-synthase and cyclooxygenase/lipooxygenase systems in development of experimental ulcerative colitis. J Physiol Pharmacol 2011;62:65–73.

    CAS  PubMed  Google Scholar 

  10. Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007;446:557–61.

    Article  CAS  PubMed  Google Scholar 

  11. Frey MR, Edelblum KL, Mullane MT, Liang D, Polk DB. The ErbB4 growth factor receptor is required for colon epithelial cell survival in the presence of TNF. Gastroenterology 2009;136:217–26.

    Article  CAS  PubMed  Google Scholar 

  12. Edelblum KL, Yan F, Yamaoka T, Polk DB. Regulation of apoptosis during homeostasis and disease in the intestinal epithelium. Inflamm Bowel Dis 2006;12:413–24.

    Article  PubMed  Google Scholar 

  13. Iwamoto M, Koji T, Makiyama K, Kobayashi N, Nakane PK. Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol 1996;180:152–9.

    Article  CAS  PubMed  Google Scholar 

  14. Zeissig S, Bojarski C, Buergel N, Mankertz J, Zeitz M, Fromm M, et al. Downregulation of epithelial apoptosis and barrier repair in active Crohn’s disease by tumour necrosis factor alpha antibody treatment. Gut 2004;53:1295–302.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Gonçalves LM, Valente IM, Rodrigues JA. An overview on cardamonin. J Med Food 2014; 17:633–40.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Niu P-G, Zhang Y-X, Shi D-H, Liu Y, Chen Y-Y, Deng J. Cardamonin inhibits metastasis of lewis lung carcinoma cells by decreasing mTOR activity. PLoS One 2015;10:e0127778.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Park S, Gwak J, Han SJ, Oh S. Cardamonin suppresses the proliferation of colon cancer cells by promoting β-catenin degradation. Biol Pharm Bull 2013;36:1040–1.

    Article  CAS  PubMed  Google Scholar 

  18. Doug H, Chen SX, Xu HX, Kadota S, Namba T. A new antiplatelet diarylheptanoid from Alpinia blepharocalyx. J Nat Prod 1998;61:142–4.

    Article  CAS  PubMed  Google Scholar 

  19. Wang ZT, Lau CW, Chan FL, Yao X, Chen ZY, He ZD, et al. Vasorelaxant effects of cardamonin and alpinetin from Alpinia henryi K. Schum. J Cardiovasc Pharmacol 2001;37:596–606.

    Article  CAS  PubMed  Google Scholar 

  20. Israf DA, Khaizurin TA, Syahida A, Lajis NH, Khozirah S. Cardamonin inhibits COX and iNOS expression via inhibition of p65NF-kappaB nuclear translocation and Ikappa-B phosphorylation in RAW 264.7 macrophage cells. Mol Immunol 2007;44:673–9.

    Article  CAS  PubMed  Google Scholar 

  21. Kim Y-J, Ko H, Park J-S, Han I-H, Amor EC, Lee JW, et al. Dimethyl cardamonin inhibits lipopolysaccharide-induced inflammatory factors through blocking NF-kappaB p65 activation. Int Immunopharmacol 2010; 10:1127–34.

    Article  CAS  PubMed  Google Scholar 

  22. Ahmad S, Israf DA, Lajis NH, Shaari K, Mohamed H, Wahab AA, et al. Cardamonin, inhibits pro-inflammatory mediators in activated RAW 264.7 cells and whole blood. Eur J Pharmacol 2006;538:188–94.

    Article  CAS  PubMed  Google Scholar 

  23. Hatziieremia S, Gray AI, Ferro VA, Paul A, Plevin R. The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFkappaB signalling pathways in monocytes/macrophages. Br J Pharmacol 2006;149:188–98.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Dodda D, Chhajed R, Mishra J. Protective effect of quercetin against acetic acid induced inflammatory bowel disease (IBD) like symptoms in rats: possible morphological and biochemical alterations. Pharmacol Rep 2014;66:169–73.

    Article  CAS  PubMed  Google Scholar 

  25. El-Naga RN. Pre-treatment with cardamonin protects against cisplatin-induced nephrotoxicity in rats: impact on NOX-1, inflammation and apoptosis. Toxicol Appl Pharmacol 2014;274:87–95.

    Article  CAS  PubMed  Google Scholar 

  26. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238–49.

    CAS  PubMed  Google Scholar 

  27. Tsune I, Ikejima K, Hirose M, Yoshikawa M, Enomoto N, Takei Y, et al. Dietary glycine prevents chemical-induced experimental colitis in the rat. Gastroenterology 2003;125:775–85.

    Article  CAS  PubMed  Google Scholar 

  28. Bobin-Dubigeon C, Collin X, Grimaud N, Robert JM, Le Baut G, Petit JY. Effects of tumour necrosis factor-alpha synthesis inhibitors on rat trinitrobenzene sulphonic acid-induced chronic colitis. Eur J Pharmacol 2001;431:103–10.

    Article  CAS  PubMed  Google Scholar 

  29. Roelofs JJTH, Rouschop KMA, Leemans JC, Claessen N, de Boer AM, Frederiks WM, et al. Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injury. J Am Soc Nephrol 2005;17:131–40.

    Article  PubMed  CAS  Google Scholar 

  30. Bancroft J, Stevens A. Theory and practice of histological techniques. 4th ed. Edinburgh: Churchill Livingstone; 1996.

    Google Scholar 

  31. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302–10.

    Article  CAS  PubMed  Google Scholar 

  32. Randhawa PK, Singh K, Singh N, Jaggi AS. A review on chemical-induced inflammatory bowel disease models in rodents. Korean J Physiol Pharmacol 2014;18:279–88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Latifi G, Ghannadi A, Minaiyan M. Anti-inflammatory effect of volatile oil and hydroalcoholic extract of Rosa damascena Mill on acetic acid-induced colitis in rats. Res Pharm Sci 2016; 10:514–22.

    Google Scholar 

  34. V P, C G. Protective effect of marine mangrove Rhizophora apiculata on acetic acid induced experimental colitis by regulating anti-oxidant enzymes, inflammatory mediators and nuclear factor-kappa B subunits. Int Immunopharmacol 2014;18:124–34.

    Article  CAS  Google Scholar 

  35. Ibrahim RY, Hassan AI, Al-Adham EK. The anti-ulcerative colitis effects of Annona squamosa Linn: leaf aqueous extract in experimental animal model. Int J Clin Exp Med 2015;8:21861–70.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Sakthivel KM, Guruvayoorappan C. Protective effect of Acacia ferruginea against ulcerative colitis via modulating inflammatory mediators, cytokine profile and NF-κB signal transduction pathways. J Environ Pathol Toxicol Oncol 2014;33:83–98.

    Article  PubMed  Google Scholar 

  37. El-Gowelli HM, Saad EI, Abdel-Galil A-GA, Ibrahim ER. Co-administration of α-lipoic acid and cyclosporine aggravates colon ulceration of acetic acid-induced ulcerative colitis via facilitation of NO/COX-2/miR-210 cascade. Toxicol Appl Pharmacol 2015;288:300–12.

    Article  CAS  PubMed  Google Scholar 

  38. Ren G, Sun A, Deng C, Zhang J, Wu X, Wei X, et al. The anti-inflammatory effect and potential mechanism of cardamonin in DSS-induced colitis. Am J Physiol Gastrointest Liver Physiol 2015;309:G517–527.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Mannasaheb BAA, Kulkarni PV, Sangreskopp MA, Savant C, Mohan A. Protective effect of Agave americana Linn: leaf extract in acetic acid-induced ulcerative colitis in rats. Ayu 2015;36:101–6.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Zheng L, Gao Z-Q, Wang S-X. A chronic ulcerative colitis model in rats. World J Gastroenterol 2000;6:150–2.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Dijkstra G, Moshage H, van Dullemen HM, de Jager-Krikken A, Tiebosch AT, Kleibeuker JH, et al. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol 1998;186:416–21.

    Article  CAS  PubMed  Google Scholar 

  42. Krieglstein CF, Cerwinka WH, Laroux FS, Salter JW, Russell JM, Schuermann G, et al. Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J Exp Med 2001;194:1207–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Yasukawa K, Tokuda H, Tun X, Utsumi H, Yamada K. The detrimental effect of nitric oxide on tissue is associated with inflammatory events in the vascular endothelium and neutrophils in mice with dextran sodium sulfate-induced colitis. Free Radic Res 2012;46:1427–36.

    Article  CAS  PubMed  Google Scholar 

  44. Brennan FM, Maini RN, Feldmann M. Cytokine expression in chronic inflammatory disease. Br Med Bull 1995;51:368–84.

    Article  CAS  PubMed  Google Scholar 

  45. Morris KR, Lutz RD, Choi H-S, Kamitani T, Chmura K, Chan ED. Role of the NF-kappaB signaling pathway and kappaB cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide. Infect Immun 2003;71:1442–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Inoue H, Tanabe T. Transcriptional role of the nuclear factor kappa B site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells. Biochem Biophys Res Commun 1998;244:143–8.

    Article  CAS  PubMed  Google Scholar 

  47. Atreya I, Atreya R, Neurath MF. NF-kappaB in inflammatory bowel disease. J Intern Med 2008;263:591–6.

    Article  CAS  PubMed  Google Scholar 

  48. Sedger LM, McDermott MF. TNF and TNF-receptors: from mediators of cell death and inflammation to therapeutic giants — past, present and future. Cytokine Growth Factor Rev 2014;25:453–72.

    Article  CAS  PubMed  Google Scholar 

  49. Lee I-A, Bae E-A, Hyun Y-J, Kim D-H. Dextran sulfate sodium and 2,4,6-trinitrobenzene sulfonic acid induce lipid peroxidation by the proliferation of intestinal gram-negative bacteria in mice. J Inflamm 2010;7:7.

    Article  CAS  Google Scholar 

  50. Piechota-Polanczyk A, Fichna J. Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases. Naunyn Schmiedebergs Arch Pharmacol 2014;387:605–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Ruemmele FM, Seidman EG, Lentze MJ. Regulation of intestinal epithelial cell apoptosis and the pathogenesis of inflammatory bowel disorders. J Pediatr Gastroenterol Nutr 2002;34:254–60.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmacology and Toxicology Department, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt

    Azza Abdelfattah Ali, Ekram Nemr Abd Al Haleem, Sahar Abdel-Hafeez Khaleel & Amany Said Sallam

Authors
  1. Azza Abdelfattah Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ekram Nemr Abd Al Haleem
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sahar Abdel-Hafeez Khaleel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Amany Said Sallam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sahar Abdel-Hafeez Khaleel.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ali, A.A., Abd Al Haleem, E.N., Khaleel, S.AH. et al. Protective effect of cardamonin against acetic acid-induced ulcerative colitis in rats. Pharmacol. Rep 69, 268–275 (2017). https://doi.org/10.1016/j.pharep.2016.11.002

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.pharep.2016.11.002

Keywords

Search

Navigation